Sivia Capital Partners LLC Buys Shares of 2,507 Colgate-Palmolive (NYSE:CL)

Sivia Capital Partners LLC purchased a new position in shares of Colgate-Palmolive (NYSE:CL) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,507 shares of the company’s stock, valued at approximately $228,000.

Several other hedge funds also recently modified their holdings of the company. Wedmont Private Capital raised its holdings in Colgate-Palmolive by 53.1% during the 4th quarter. Wedmont Private Capital now owns 12,391 shares of the company’s stock worth $1,070,000 after purchasing an additional 4,295 shares during the last quarter. Capital Investment Advisors LLC raised its stake in Colgate-Palmolive by 2.5% during the fourth quarter. Capital Investment Advisors LLC now owns 9,634 shares of the company’s stock worth $876,000 after buying an additional 238 shares during the last quarter. Brookstone Capital Management boosted its position in Colgate-Palmolive by 12.0% during the fourth quarter. Brookstone Capital Management now owns 19,455 shares of the company’s stock valued at $1,769,000 after acquiring an additional 2,089 shares during the last quarter. Trust Co. of Toledo NA OH grew its holdings in Colgate-Palmolive by 3.8% during the 4th quarter. Trust Co. of Toledo NA OH now owns 18,096 shares of the company’s stock worth $1,645,000 after acquiring an additional 663 shares during the period. Finally, Fiduciary Alliance LLC bought a new position in shares of Colgate-Palmolive in the 4th quarter worth about $4,066,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. TD Cowen lowered their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Piper Sandler decreased their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Stifel Nicolaus cut Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price objective for the company from $105.00 to $101.00 in a research note on Monday, October 28th. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Wells Fargo & Company cut their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $103.63.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock traded up $0.61 during mid-day trading on Monday, reaching $86.97. The company’s stock had a trading volume of 5,275,657 shares, compared to its average volume of 4,862,452. The firm’s fifty day moving average price is $92.62 and its two-hundred day moving average price is $98.06. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a 12-month low of $79.69 and a 12-month high of $109.30. The company has a market capitalization of $71.06 billion, a P/E ratio of 24.92, a PEG ratio of 3.31 and a beta of 0.44.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.30%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Insider Activity

In related news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.